Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment

Figure 1

In vitro culture of leukemia cells. (a) AML cells obtained from eight cohorts were cultured continuously, and the growth rate of each generation was recorded. (b) ALL cells obtained from six cohorts were cultured continuously, and the growth rate of each generation was recorded. (c) The AML cell surface markers (CD33 and CD34) of P0 and P5 generations were analyzed by FACS analysis. (d) The ALL cell surface markers (CD45 and CD20) of P0 and P5 generations were analyzed by FACS analysis.

(a)

(b)

(c)

(d)